Exponent (NASDAQ: EXPO) insider transactions
In the twelve months to 10 November 2026, executives and directors of Exponent reported 23 open-market sales of 47,249 shares ($3.1m) and 1 open-market purchase of 184 shares ($12,594), by 7 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 3 November 2026 | Reiss Richard | Group Vice President | Open-market sale | −1,280 | $86.44 | 1,008 | Form 4 |
| 18 September 2026 | Souri Shukri Jeries | Group Vice President | Open-market purchase | +184 | $68.45 | 40,873 | Form 4 |
| 17 August 2026 | Corrigan Catherine | Chief Executive Officer | Option exercise, 10b5-1 plan | +2,379 | $29.05 | 130,815 | Form 4 |
| 17 August 2026 | Corrigan Catherine | Chief Executive Officer | Open-market sale, 10b5-1 plan | −1,707 | $66.28 | 129,108 | Form 4 |
| 28 July 2026 | Corrigan Catherine | Chief Executive Officer | Option exercise | +12,665 | $37.45 | 128,436 | Form 4 |
| 15 July 2026 | Corrigan Catherine | Chief Executive Officer | Option exercise, 10b5-1 plan | +2,379 | $29.05 | 117,508 | Form 4 |
| 15 July 2026 | Corrigan Catherine | Chief Executive Officer | Open-market sale, 10b5-1 plan | −1,737 | $62.78 | 115,771 | Form 4 |
| 25 June 2026 | Corrigan Catherine | Chief Executive Officer | Option exercise | +7,872 | $25.41 | 115,129 | Form 4 |
| 15 June 2026 | Corrigan Catherine | President & CEO | Option exercise, 10b5-1 plan | +3,225 | $25.41 | 108,996 | Form 4 |
| 15 June 2026 | Corrigan Catherine | President & CEO | Open-market sale, 10b5-1 plan | −2,326 | $57.13 | 106,670 | Form 4 |
| 15 June 2026 | Corrigan Catherine | President & CEO | Option exercise, 10b5-1 plan | +2,380 | $29.05 | 109,050 | Form 4 |
| 15 June 2026 | Corrigan Catherine | President & CEO | Open-market sale, 10b5-1 plan | −1,793 | $57.13 | 107,257 | Form 4 |
| 3 June 2026 | Johnston Paul R | Director | Option exercise | +2,009 | — | 62,940 | Form 4 |
| 3 June 2026 | Zumwalt Debra | Director | Option exercise | +2,009 | — | 31,830 | Form 4 |
| 3 June 2026 | Richardson Karen A | Director | Option exercise | +2,009 | — | 2,009 | Form 4 |
| 3 June 2026 | Brown George H. | Director | Option exercise | +2,009 | — | 10,730 | Form 4 |
| 3 June 2026 | Lindstrom Carol | Director | Option exercise | +2,009 | — | 9,405 | Form 4 |
| 26 May 2026 | James Bradley A | Group Vice President | Open-market sale | −2,000 | $57.47 | 1,105 | Form 4 |
| 19 May 2026 | Reiss Richard | Group Vice President | Open-market sale | −1,672 | $58.65 | 2,288 | Form 4 |
| 15 May 2026 | Corrigan Catherine | President & CEO | Option exercise, 10b5-1 plan | +3,226 | $25.41 | 107,585 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Exponent page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.